Implantable Reservoir for Iontophoresis Drug Delivery System
Summary
The USPTO has published a new patent application (US20260083966A1) for an implantable reservoir designed for iontophoresis drug delivery systems. The application details a reservoir for local drug delivery through internal or external body tissue, potentially including chemotherapeutic agents or ribonucleic acid molecules.
What changed
This document is a publication of a patent application filed with the USPTO, detailing an implantable reservoir for iontophoresis drug delivery. The invention focuses on a system for local drug delivery through a target site using an electric field, with potential applications for chemotherapeutic drugs or RNA molecules. The application number is 19339069, and it was filed on September 24, 2025.
This patent application publication does not impose new regulatory obligations. It represents an early stage in the patent process. Companies involved in medical devices, drug delivery, or pharmaceuticals may find the technical details of the invention relevant for research and development purposes. No compliance actions are required based on this publication.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RESERVOIR FOR USE WITH A MEDICAL DEVICE AND SYSTEM FOR INTERVENTIONAL DRUG DELIVERY
Application US20260083966A1 Kind: A1 Mar 26, 2026
Inventors
William Daunch, Javier de Ana, Casey Haigh, Brendan Berkel, Elliott Hannah
Abstract
A surgically implantable reservoir is provided for implantation into a patient for use in an iontophoresis system. The reservoir and system are used for local drug delivery through a target site of internal or external body tissue. The iontophoresis system includes a source electrode and a counter electrode in electrical communication with the source electrode for forming a localized electric field at the target site. A fluid cargo may comprise a drug solution to be delivered to target tissue. For example, a chemotherapeutic drug solution or any other fluid polar substance may be delivered via the reservoir. In one embodiment, the fluid cargo may include ribonucleic acid molecules.
CPC Classifications
A61N 1/325 A61K 9/0009 A61K 9/0024 A61K 31/7105 A61M 31/002 A61N 1/05 A61M 2205/04
Filing Date
2025-09-24
Application No.
19339069
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.